[PDF][PDF] Lamprene (clofazimine) in leprosy
SJ Yawalkar, W Vischer - Lepr. Rev, 1979 - leprev.ilsl.br
SJ Yawalkar, W Vischer
Lepr. Rev, 1979•leprev.ilsl.brIn 1962, Browne and Hogerzeil1 first reported on the efficacy of® Lamprene (B 663, G
30,320, clofazimine) in leprosy patients in Nigeria. At present, Lamprene is one of the
extensively used antileprosy drugs; it is effective in the prevention2-4 and treatment of lepra
(ENL) reactions5 and is also useful for the treatment of dapsone-resistant leprosy cases3, 6,
7. To date, Lamprene is the only major antileprosy drug which displays an anti-infiammatory
effect and to which resistant strains of leprosy bacilli have not been reported.
30,320, clofazimine) in leprosy patients in Nigeria. At present, Lamprene is one of the
extensively used antileprosy drugs; it is effective in the prevention2-4 and treatment of lepra
(ENL) reactions5 and is also useful for the treatment of dapsone-resistant leprosy cases3, 6,
7. To date, Lamprene is the only major antileprosy drug which displays an anti-infiammatory
effect and to which resistant strains of leprosy bacilli have not been reported.
In 1962, Browne and Hogerzeil1 first reported on the efficacy of® Lamprene (B 663, G 30,320, clofazimine) in leprosy patients in Nigeria. At present, Lamprene is one of the extensively used antileprosy drugs; it is effective in the prevention2-4 and treatment of lepra (ENL) reactions5 and is also useful for the treatment of dapsone-resistant leprosy cases3, 6, 7. To date, Lamprene is the only major antileprosy drug which displays an anti-infiammatory effect and to which resistant strains of leprosy bacilli have not been reported.
leprev.ilsl.br